Phase 4 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with type 2 diabetes and are 19 years of age or older
- You have been taking a stable dose of metformin and a DPP-4 inhibitor (a type of diabetes medication) for at least the past 8 weeks
- Your HbA1c (a measure of blood sugar control over the past few months) is between 7.0% and just below 10% at the time of screening
- Your Body Mass Index (BMI) is between 18.5 and 40 at the time of screening
- You have been fully informed about the study and have agreed to participate by signing a consent form
Who may not be able to join:
- You have type 1 diabetes
- Your BMI is above 40
- You have moderate to severe kidney disease, or your kidney filtering rate (eGFR) is below 45 mL/min/1.73m² (confirm with trial site)
- You have end-stage kidney disease or are currently on dialysis
- You have heart failure that is not well controlled and significantly limits your daily activities
- You have had an uncontrolled irregular heartbeat, heart attack, unstable chest pain, heart bypass surgery, or a stroke within the past 24 weeks
- You have or have had a condition where dangerous levels of acid build up in your body, including lactic acidosis or diabetic ketoacidosis
- You are currently in or recently experienced a diabetic coma or pre-coma state
- You have had a severe low blood sugar episode while taking metformin and a DPP-4 inhibitor
- You have blood in your urine
- You are currently being treated for a thyroid condition
- You are malnourished, severely underweight, or in a generally weakened physical state
- You have a condition where your pituitary gland or adrenal glands do not work properly
- You have significant liver disease, shown by certain liver enzyme levels being more than 3 times higher than normal
- You have a serious active infection, are in the period around a surgery, or have a significant injury
- You have a history of substance abuse
- You have taken insulin or certain other diabetes medications (including sulfonylureas, thiazolidinediones, SGLT2 inhibitors, or GLP-1 receptor agonists) within the past 8 weeks
- You have taken steroid medications (corticosteroids) for more than 2 weeks in a row within the past 8 weeks, or need to take them repeatedly
- You have been diagnosed with cancer within the last 5 years
- You have taken part in another clinical trial involving an experimental drug or device within the past 12 weeks
- You are currently pregnant or breastfeeding
- You have had an allergic reaction to metformin, DPP-4 inhibitors, dapagliflozin, or related types of diabetes medications, or any of their ingredients
- You have a rare inherited condition affecting how your body processes certain sugars, such as galactose intolerance or glucose-galactose malabsorption (confirm with trial site)
- The trial doctor considers you unsuitable for the study for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Variance in HbA1c from baseline to 24 weeks on study drug
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.